Avadel Pharmaceuticals (AVDL) Other Gross PP&E Adjustments: 2011-2022
Historic Other Gross PP&E Adjustments for Avadel Pharmaceuticals (AVDL) over the last 6 years, with Sep 2022 value amounting to -$6.4 million.
- Avadel Pharmaceuticals' Other Gross PP&E Adjustments rose 5.42% to -$6.4 million in Q3 2022 from the same period last year, while for Sep 2022 it was -$26.1 million, marking a year-over-year decrease of 69.97%. This contributed to the annual value of -$4.9 million for FY2021, which is 23.85% down from last year.
- Latest data reveals that Avadel Pharmaceuticals reported Other Gross PP&E Adjustments of -$6.4 million as of Q3 2022, which was down 18.59% from -$5.4 million recorded in Q2 2022.
- Avadel Pharmaceuticals' Other Gross PP&E Adjustments' 5-year high stood at $3.8 million during Q4 2018, with a 5-year trough of -$12.6 million in Q3 2018.
- Moreover, its 3-year median value for Other Gross PP&E Adjustments was -$3.9 million (2020), whereas its average is -$4.6 million.
- As far as peak fluctuations go, Avadel Pharmaceuticals' Other Gross PP&E Adjustments plummeted by 409.08% in 2018, and later soared by 58.66% in 2019.
- Avadel Pharmaceuticals' Other Gross PP&E Adjustments (Quarterly) stood at $3.8 million in 2018, then crashed by 161.66% to -$2.4 million in 2019, then tumbled by 67.46% to -$3.9 million in 2020, then decreased by 23.85% to -$4.9 million in 2021, then climbed by 5.42% to -$6.4 million in 2022.
- Its last three reported values are -$6.4 million in Q3 2022, -$5.4 million for Q2 2022, and -$9.5 million during Q1 2022.